Can I read Granzyme B as Prognostic Biomarker in TNBC on EtoBox?

Granzyme B as Prognostic Biomarker in TNBC by Cezary Adamski is a document available to read on EtoBox.

What is Granzyme B as Prognostic Biomarker in TNBC about?

This study investigates granzyme B (GZMB) expression in the tumor microenvironment as a prognostic biomarker for patients with triple-negative breast cancer (TNBC). The findings indicate that GZMB-high patients in the PD-L1-positive group have better recurrence-free and overall survival compared to GZMB-low patients. The results suggest that GZMB could serve as a valuable prognostic marker for PD-L1-positive TNBC patients.

Author

Cezary Adamski

Language

EN